Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension
N. Alebrahimdehkordi (Giessen, Germany), O. Pak (Giessen, Germany), S. Scheibe (Giessen, Germany), M. Gierhardt (Giessen, Germany), A. Sydykov (Giessen, Germany), M. Hecker (Giessen, Germany), K. Schaefer (Giessen, Germany), W. Seeger (Giessen, Germany), H. Ghofrani (Giessen, Germany), R. Schermuly (Giessen, Germany), M. Murphy (Cambridge, United Kingdom), N. Weissmann (Giessen, Germany), N. Sommer (Giessen, Germany)
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases, Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Alebrahimdehkordi (Giessen, Germany), O. Pak (Giessen, Germany), S. Scheibe (Giessen, Germany), M. Gierhardt (Giessen, Germany), A. Sydykov (Giessen, Germany), M. Hecker (Giessen, Germany), K. Schaefer (Giessen, Germany), W. Seeger (Giessen, Germany), H. Ghofrani (Giessen, Germany), R. Schermuly (Giessen, Germany), M. Murphy (Cambridge, United Kingdom), N. Weissmann (Giessen, Germany), N. Sommer (Giessen, Germany). Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension. 1416
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: